Ultragenyx Pharmaceutical | RARE - Ebitda

株価
24.10
毎日の変更
-0.18 -0.74%
毎月
21.41%
毎年
-36.73%
Q2 予測
23.58




Ebitda 変化する 日付
Acadia Pharmaceuticals USD 35.76M 447K 2025-09
Agios Pharmaceuticals USD -115.49M 10.3M 2025-09
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
BioMarin Pharmaceutical USD -24.17M 18.91M 2025-12
Esperion Therapeutics USD -9.93M 24.99M 2025-09
Immunic USD -22.78M 753K 2024-06
Insmed USD -314.19M 31.48M 2025-12
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Kyowa Hakko Kirin JPY 45.74B 13.46B 2025-12
MacroGenics USD 21.95M 55.39M 2025-09
Moderna USD -790M 582M 2025-12
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
PTC Therapeutics USD -70.99M 91.62M 2025-12
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Sarepta Therapeutics USD -168.03M 294.45M 2025-09
Ultragenyx Pharmaceutical USD -156.79M 65.44M 2025-09
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09
Xoma USD 2.52M 7.98M 2024-06